Pacira Pharma (PCRX) Misses Q4 EPS by 5c, Sales Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Pacira Pharma (PCRX) Misses Q4 EPS by 5c, Sales Beat

Pacira Pharmaceuticals, Inc. Reports 2015 Financial Results

February 25, 2016 7:30 AM EST

-- 2015 Total Net Revenues Up 26 Percent Over 2014 ---- 2015 EXPAREL® Net Revenues Up 27 Percent Over 2014 ---- Per-Protocol Analysis of Oral Surgery Data Demonstrates Statistical Significance; Supports Launch Activities in Late Third Quarter 2016 --  -- Conference Call Today at 9 a.m. ET --

PARSIPPANY, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today provided updates on... More